Thermo Fisher Scientific Inc.
Market Cap
$223.7B
Global Rank
#70
All-Time High
$244.9B
2021-12-31
Total Growth
+0%
since 2026
Market Cap Context
- Larger than 81% of the 367 companies we track (globally).
- Equivalent to 0.7% of United States's GDP (2025 data).
- Just above: #69 Amgen Inc. ($224.1B)
- Just below: #71 L'Orรฉal S.A. ($220.7B)
- Best year: 2000 (+98%). Worst year: 1998 (-62%).
Thermo Fisher Scientific Inc. Financial Breakdown (FY 2025)
Source: Yahoo Finance โ TMO annual filings (2025) โ$44.6B revenue ยท $8.1B operating income ยท $6.7B net income
- โOperating margin: 18.2% on $44.6B in revenue.
- โR&D is 3.1% of revenue ($1.4B).
- โNet income margin: 15.0% โ $6.7B in profit.
- โFree cash flow: $6.3B (14.1% of revenue).
Cost / Operating Expenses
Total operating expenses $36.4B
Total
$36.4B
Capital Expenditures
$1.5B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$6.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
About Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
Thermo Fisher Scientific Inc. Market Cap History (2026โ2026)
Thermo Fisher Scientific Inc. vs Sector Peers by Market Cap
Compare Thermo Fisher Scientific Inc.
Ranking History
| Year | Market Cap | Rank | YoY Change |
|---|---|---|---|
| 2026 | $223.7B | #70(โ8) | +4.1% |
| 2025 | $215.0B | #62(โ9) | +11.8% |
| 2024 | $192.3B | #53(โ4) | -1.7% |
| 2023 | $195.7B | #49(โ12) | -3.4% |
| 2022 | $202.5B | #37(โ6) | -17.3% |
| 2021 | $244.9B | #31(โ8) | +43.5% |
| 2020 | $170.6B | #39(โ16) | +43.7% |
| 2019 | $118.7B | #55(โ4) | +45.6% |
| 2018 | $81.5B | #59(โ12) | +18.2% |
| 2017 | $69.0B | #71(โ17) | +35.1% |
| 2016 | $51.1B | #88(โ14) | -0.1% |
| 2015 | $51.1B | #74(โ11) | +13.8% |
| 2014 | $44.9B | #85(โ4) | +13.1% |
| 2013 | $39.7B | #81(โ35) | +75.9% |
| 2012 | $22.6B | #116(โ16) | +42.8% |
| 2011 | $15.8B | #132(โ10) | -18.8% |
| 2010 | $19.5B | #122(โ2) | +16.1% |
| 2009 | $16.8B | #120(โ3) | +40.0% |
| 2008 | $12.0B | #117(โ9) | -40.9% |
| 2007 | $20.3B | #108(โ16) | +27.4% |
| 2006 | $15.9B | #124(โ21) | +50.3% |
| 2005 | $10.6B | #145(โ24) | -0.2% |
| 2004 | $10.6B | #121(โ4) | +19.8% |
| 2003 | $8.9B | #117(โ4) | +25.2% |
| 2002 | $7.1B | #113(โ1) | -15.7% |
| 2001 | $8.4B | #112(โ6) | -6.8% |
| 2000 | $9.0B | #106(โ12) | +98.3% |
| 1999 | $4.5B | #118(โ23) | -11.4% |
| 1998 | $5.1B | #95(โ53) | -61.5% |
| 1997 | $13.3B | #42(โ4) | +6.7% |
| 1996 | $12.5B | #38(โ3) | +19.0% |
| 1995 | $10.5B | #35 | +73.8% |
| 1994 | $6.0B | #35 |
Other Healthcare Companies
FAQ
What is Thermo Fisher Scientific Inc.'s market cap?
Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $223.7B, making it the #70 largest company in the world by market cap.
What was Thermo Fisher Scientific Inc.'s highest market cap?
Thermo Fisher Scientific Inc.'s all-time high market cap was $244.9B, reached in 2021-12-31. Its highest rank was #31 in 2021.
What sector is Thermo Fisher Scientific Inc. in?
Thermo Fisher Scientific Inc. is in the Healthcare sector, specifically the Diagnostics & Research industry. It is based in United States.
How has Thermo Fisher Scientific Inc.'s market cap changed over time?
Thermo Fisher Scientific Inc. has been tracked since 2026. Its market cap has grown by 0% from $223.7B in 2026 to $223.7B today.